Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|February 15, 2014
Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agentsBing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Blood Cancer Journal|April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Molecular Cancer Therapeutics|April 1, 2022
Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem CellsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood|July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemiaBing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Molecular Cancer Therapeutics|March 9, 2017
Focal Adhesion Kinase as a Potential Target in AML and MDSBing Z Carter, Po Yee Mak, Xiangmeng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid LeukemiaXuejie Jiang, Po Yee Mak, Hong Mu, et al.
Leukemia|December 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Haematologica|November 4, 2021
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemiaSean M Post, Huaxian Ma, Prerna Malaney, et al.
Translational Oncology|February 3, 2022
Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AMLKotoko Yamatani, Tomohiko Ai, Kaori Saito, et al.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
Pageof 3